CURI (CuriosityStream Inc. Class A Common Stock) Stock Analysis - News

CuriosityStream Inc. Class A Common Stock (CURI) is a publicly traded Communication Services sector company. As of May 21, 2026, CURI trades at $2.60 with a market cap of $162.74M and a P/E ratio of -20.27. CURI moved -2.99% today. Year to date, CURI is -30.67%; over the trailing twelve months it is -58.80%. Its 52-week range spans $1.47 to $7.15. Analyst consensus is strong buy with an average price target of $5.33. Rallies surfaces CURI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in CURI news today?

CuriosityStream Posts Positive $0.9M EBITDA on $15.2M Revenue, Incurs $1.3M Loss: CuriosityStream reported Q1 revenue rose 3% year-over-year to $15.2 million with adjusted EBITDA turning positive at $0.9 million for the fifth consecutive quarter. Net loss widened to $1.3 million as marketing and G&A expenses jumped 27% while subscription revenue plateaued and licensing remained volatile.

CURI Key Metrics

Key financial metrics for CURI
MetricValue
Price$2.60
Market Cap$162.74M
P/E Ratio-20.27
EPS$-0.13
Dividend Yield0.09%
52-Week High$7.15
52-Week Low$1.47
Volume0
Avg Volume0
Revenue (TTM)$71.73M
Net Income$-8.07M
Gross Margin0.00%

Latest CURI News

Recent CURI Insider Trades

  • Hayden Phillip Brady sold 17.47K (~$65.66K) on Jan 2, 2026.
  • Hayden Phillip Brady sold 2.00K (~$9.18K) on Dec 15, 2025.
  • Cudahy Theresa Ellen sold 5.77K (~$28.70K) on Dec 10, 2025.

CURI Analyst Consensus

3 analysts cover CURI: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.33.

Common questions about CURI

What changed in CURI news today?
CuriosityStream Posts Positive $0.9M EBITDA on $15.2M Revenue, Incurs $1.3M Loss: CuriosityStream reported Q1 revenue rose 3% year-over-year to $15.2 million with adjusted EBITDA turning positive at $0.9 million for the fifth consecutive quarter. Net loss widened to $1.3 million as marketing and G&A expenses jumped 27% while subscription revenue plateaued and licensing remained volatile.
Does Rallies summarize CURI news?
Yes. Rallies summarizes CURI news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CURI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURI. It does not provide personalized investment advice.
CURI

CURI